Jean-Luc Herbeaux to become Hovione CEO
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
C&EN, 26 September 2021
Investment in Hovione Tejo will expand industrial capacity and strengthen the company’s global leadership in spray drying and other advanced pharmaceutical manufacturing technologies.
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Outsourced Pharma, April 2023
Showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction